BioCentury
ARTICLE | Company News

Paladin acquires Canadian rights to LLY's Tapazole

December 22, 2000 8:00 AM UTC

Eli Lilly (LLY) granted Paladin (TSE:PLB) Canadian rights to its Tapazole methimazole, a thyroid hormone synthesis inhibitor to treat hyperthyroidism. ...